Cargando…

Myopathy secondary to empagliflozin therapy in type 2 diabetes

SUMMARY: Sodium/glucose co-transporter 2 (SGLT2) inhibitors are novel oral hypoglycaemic agents that are increasingly used in the management of type 2 diabetes mellitus (T2DM). They are now recommended as second-line pharmacotherapy (in conjunction with metformin) in patients with type 2 diabetes an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Frank, Hall, Stephen, Bach, Leon A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2020
Materias:	Unusual Effects of Medical Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159254/ https://www.ncbi.nlm.nih.gov/pubmed/32478668 http://dx.doi.org/10.1530/EDM-20-0017

Ejemplares similares

Central serous chorioretinopathy secondary to intramuscular testosterone therapy
por: Lockhart, M, et al.
Publicado: (2023)

Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes
por: Malavazos, Alexis Elias, et al.
Publicado: (2023)

Simultaneous onset of type 1 diabetes mellitus and silent thyroiditis under durvalumab treatment
por: León Mengíbar, Jose, et al.
Publicado: (2019)

Opioid-induced secondary adrenal insufficiency presenting as hypercalcaemia
por: Lee, Angela S, et al.
Publicado: (2015)

Adrenal insufficiency in a woman secondary to standard-dose inhaled fluticasone propionate therapy
por: Hay, Casey M, et al.
Publicado: (2014)

New onset autoimmune diabetes mellitus and hypothyroidism secondary to pembrolizumab in a patient with metastatic lung cancer
por: Cunha, Clara, et al.
Publicado: (2022)

Honey dressing on a leg ulcer with tendon exposure in a patient with type 2 diabetes
por: Teobaldi, Ilaria, et al.
Publicado: (2018)

Diabetic ketoacidosis following PEG-asparaginase therapy
por: Ahmad, Miriam Hinaa, et al.
Publicado: (2018)

Presentation of new onset type 1 diabetes with diabetic ketoacidosis and hyperosmolar hyperglycaemia after a single dose of nivolumab and ipilimumab
por: Stathi, Dimitra, et al.
Publicado: (2023)

Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral
por: Kusuki, Kazuhisa, et al.
Publicado: (2020)

One year remission of type 1 diabetes mellitus in a patient treated with sitagliptin
por: Lima-Martínez, Marcos M, et al.
Publicado: (2014)

GH replacement causing acute hyperglycaemia and ketonuria in a type 1 diabetic patient
por: Cavlan, Dominic, et al.
Publicado: (2013)

Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump
por: Boronat, Mauro, et al.
Publicado: (2015)

Low carbohydrate diet and improved glycaemic control in a patient with type one diabetes
por: Eiswirth, Mirjam, et al.
Publicado: (2018)

Hyponatraemia secondary to nivolumab-induced primary adrenal failure
por: Trainer, Harris, et al.
Publicado: (2016)

Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3
por: Pinheiro, Marcelo Maia, et al.
Publicado: (2016)

Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis
por: Rafey, Mohammed Faraz, et al.
Publicado: (2019)

Diabetic ketoacidosis after the treatment of anaphylaxis
por: Brenner, Daniel S, et al.
Publicado: (2022)

Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism
por: Patel, Shivani, et al.
Publicado: (2019)

New-onset insulin-dependent diabetes due to nivolumab
por: Zaied, Ali A, et al.
Publicado: (2018)

Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis
por: Tzoulis, Ploutarchos, et al.
Publicado: (2018)

Diabetes insipidus in a patient with PCOS treated with Depo-Provera
por: Martinez, Amanda I, et al.
Publicado: (2022)

Adrenal insufficiency in acute oral opiate therapy
por: Policola, Caterina, et al.
Publicado: (2014)

Stress cardiomyopathy (Takotsubo) following radioactive iodine therapy
por: Dimakopoulou, Anastasia, et al.
Publicado: (2015)

Autoimmune hypothyroidism and trastuzumab therapy: a rare association
por: Lopes, Valentim, et al.
Publicado: (2023)

Spurious HbA1c results in patients with diabetes treated with dapsone
por: Aljenaee, Khaled, et al.
Publicado: (2019)

Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies
por: Gomez-Peralta, Fernando, et al.
Publicado: (2018)

Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction
por: Ifie, Eseoghene, et al.
Publicado: (2019)

Alterations in corneal nerves following crack cocaine use mimic diabetes-induced nerve damage
por: Stuard, Whitney L, et al.
Publicado: (2017)

Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
por: da Silva, Tiago Nunes, et al.
Publicado: (2018)

Combination immune checkpoint inhibitor therapy nivolumab and ipilimumab associated with multiple endocrinopathies
por: Gunawan, Florence, et al.
Publicado: (2018)

A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement
por: Ando, Akihiko, et al.
Publicado: (2018)

A novel melanoma therapy stirs up a storm: ipilimumab-induced thyrotoxicosis
por: Yu, Christine, et al.
Publicado: (2015)

Cannabis alleviates neuropathic pain and reverses weight loss in diabetic neuropathic cachexia in a previous heroin abuser
por: Naccache, Deeb Daoud
Publicado: (2020)

A surprising treatment response in a patient with rare isolated growth hormone deficiency, type IB
por: Amar, Jordan Yardain, et al.
Publicado: (2017)

Onset of Graves' disease during long-term immunosuppressive therapy in a patient with membranous nephropathy
por: Iwasaki, Hiroaki
Publicado: (2015)

Fluticasone furoate induced iatrogenic Cushing syndrome in a pediatric patient receiving anti-retroviral therapy
por: van den Berg, S A A, et al.
Publicado: (2017)

Graves’ disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy
por: Ludgate, S, et al.
Publicado: (2021)

Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
por: Kaur, Arshpreet, et al.
Publicado: (2015)

Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor
por: Oddie, Philip D, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_44fugp5vpmgesqa74oi37o3k8c